Ibnsina Pharma ranked first in non-pharma product distribution across pharmacies in Egypt during the first nine months of 2025.

Prime Minister Mostafa Madbouly has directed the rapid preparation of investment opportunities in Egypt’s health sector for the next decade, coupled with clear partnership mechanisms, the Golden License, and standard contracts to attract private sector participation.

The state-owned pharmaceutical firm HoldiPharma signed a partnership agreement with US-based Dawah Pharma to establish a joint venture for the manufacturing and export of pharmaceuticals and nutritional supplements to international markets, including North America and Europe.

Prime Minister Mostafa Madbouly witnessed the signing of a shareholders' agreement to establish a factory for the local production of blood collection bags in the Suez Canal Economic Zone (SCZone).

Prime Minister Mostafa Madbouly has witnessed the signing of a strategic alliance between Gypto Pharma – Egyptian Medicine City and the US-based Dawah Pharmaceuticals to boost local pharmaceutical manufacturing and secure the US Food and Drug Administration (FDA) prequalification for exports to the American market.

Talaat Moustafa Group has entered a strategic partnership with Alameda Group, a leading international hospital operator, to develop and manage high-quality medical and healthcare services in its projects.

Italy’s San Donato Hospital Group plans to invest $100 million in the first phase of a new hospital project in Egypt, with further expansion across several governorates.

The Arab Company for Pharmaceutical Raw Materials (Arab API) and the General Authority for the Suez Canal Economic Zone (SCZone), represented by the Economic Zone Investment Company Egypt's first multi-purpose factory for raw pharmaceutical materials.

The Egyptian medicine city Gypto Pharma is in advanced negotiations to finalize agreements with two international firms in the first half (H1) of 2025.

Egypt has officially launched the Egyptian Vaccine Manufacturers Alliance (EVMA), an initiative that aims to localize vaccine production and expand exports across Africa.

Egypt is setting a comprehensive national strategy to localize vaccine production, aiming to reduce reliance on imports, strengthen local manufacturing, and position Egypt as a key regional exporter.

Egypt is targeting to increase its medical exports by approximately 15% in 2025 to reach $1.5 billion, from the projected $1.3 billion by the end of 2024.

The Egyptian cabinet approved a draft law aimed at regulating medical liability and enhancing patient protection.

M42, an Abu Dhabi-based AI-driven healthcare firm, is considering new expansion opportunities in Egypt as part of its strategy to extend its advanced healthcare services globally.

The Suez Canal Economic Zone (SCZone) is set to establish a dedicated pharmaceutical industrial zone covering 4 million square meters (sqm), SCZone's Head Waleid Gamal El-Dien announced during his participation in the fourth edition of the PharmaRegAfriSummit.

Egyptian pharmaceutical companies need $1 billion in the fourth quarter (Q4) of 2024 to import essential raw materials and production inputs.

Fujifilm Middle East and Africa has officially opened a new office in New Cairo, marking a key step in expanding its footprint in Egypt and the wider region.

Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents (Rameda) has completed its largest acquisition to date, securing a top-selling anti-diabetic product used to treat type 2 diabetes.

Egypt has joined a new $1.5 billion primary health financing platform launched by the World Health Organization (WHO) and three multilateral development banks: the African Development Bank (AfDB), the European Investment Bank (EIB), and the Islamic Development Bank (IDB)

Minister of Health and Population Khaled Abdel Ghaffar announced that E. coli bacteria is the cause of recent illnesses in Aswan, leading to widespread symptoms of intestinal flu among residents.